Rich Tinsley has over 20 years of life sciences consulting experience and is a recognized leader in strategy, commercialization, lifecycle management, and sophisticated forecast modeling. 

Prior to joining RxC International, Rich was a Senior Partner at Putnam Associates. Also, he worked for Bain & Company, where he advised senior executives at 6 of the top 10 Biopharma companies and many smaller ones.  Rich has worked in rare diseases, HIV, oncology, neurology, diagnostics, and other specialty markets.  In both positions, Rich was responsible for setting the overall firm’s marketing strategy, optimizing its sales force investment, and managing the back office operations.  

Rich served on several boards, including the Massachusetts Board of Registration in Pharmacy, the Sudbury Board of Education, and Diagnostyx, Inc.  Rich led the expert panel on gene therapy at NYBIO.  His publications include several white papers and journal articles. 

Rich has a B.S. in Economics and Finance from The Wharton School at the University of Pennsylvania and an M.B.A. from Stanford University Graduate School of Business. 

Recent Publications

Planning for Gene Therapy Success

RxC International · 2015